BioNote, Inc. (KRX:377740)
South Korea · Delayed Price · Currency is KRW 5,840.00
+280.00 (5.04%)
At close: Jan 30, 2026
BioNote Market Cap
BioNote has a market cap or net worth of 591.95 billion as of January 30, 2026. Its market cap has increased by 20.59% in one year.
Market Cap
591.95B
Enterprise Value
245.47B
Revenue
115.09B
Ranking
n/a
PE Ratio
5.03
Stock Price
5,840.00
Market Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 591.95B, a decrease of -45.44%. That is a compound annual growth rate of -17.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 591.95B | 6.76% |
| Dec 30, 2025 | 554.45B | 15.35% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
| Dec 22, 2022 | 1.08T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CLASSYS | 4.44T |
| T&L Co., Ltd. | 399.16B |
| Value Added Technology | 295.90B |
| Vieworks | 213.68B |
| Dongbang Medical | 160.38B |
| Shinhung | 127.87B |
| EOFLOW | 51.11B |
| PCL, Inc. | 17.87B |